COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 2 of 2 for:    GLS-5300

Phase I, Open Label Dose Ranging Safety Study of GLS-5300 in Healthy Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02670187
Recruitment Status : Completed
First Posted : February 1, 2016
Last Update Posted : January 9, 2019
Inovio Pharmaceuticals
Walter Reed Army Institute of Research (WRAIR)
Information provided by (Responsible Party):
GeneOne Life Science, Inc.